Plain-English translation of NCT06622434 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
France
Phase
Safety & dosing / Early efficacy
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
ALTEVAX SAS
Enrollment target
~35 participants
Started
November 2024
Primary completion
March 2028
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Antoine CARPENTIER, Pr
APHP- Hôpital Saint Louis
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.